Cargando…
Optimization of In Vitro Expansion and Activation of Human Natural Killer Cells against Breast Cancer Cell Line
BACKGROUND: Regarding to the increase of cancer deaths in recent years and disability of common therapies to eradicate cancers, as well as expansion of Natural Killer (NK) cell therapy, it seems so vital to find new useful therapies against cancers. Breast cancer is the second main cause of cancer d...
Autores principales: | Peighambarzadeh, Farzaneh, Najafalizadeh, Anahita, Esmaeil, Nafiseh, Rezaei, Abbas, Ashrafi, Farzaneh, Ganjalikhani Hakemi, Mazdak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035457/ https://www.ncbi.nlm.nih.gov/pubmed/32153734 |
Ejemplares similares
-
siRNA Delivery Improvement by Co-formulation of Different Modified Polymers in Erythroleukemic Cell Line K562
por: Ganjalikhani hakemi, Mazdak, et al.
Publicado: (2013) -
Positive and Negative Regulation of Th17 Cell
Differentiation: Evaluating The Impact
of RORC2
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2014) -
Innate lymphoid cells and cytokines of the novel subtypes of helper T cells in asthma
por: Sherkat, Roya, et al.
Publicado: (2014) -
RORC2 Gene Silencing in Human Th17 Cells by siRNA: Design and Evaluation of Highly Efficient siRNA
por: Hakemi, Mazdak Ganjalikhani, et al.
Publicado: (2013) -
Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
por: Homayouni, Vida, et al.
Publicado: (2016)